肝硬化食管静脉曲张破裂出血是消化内科常见的急危重症,病死率高达22％～84％。硬化剂治疗对控制出血及预防再出血疗效肯定,但操作时往往受限于出血时的视野不清,注射针眼涌血及渗血。虽然注射硬化剂后可附加气囊或套管进行压迫,但增加了患者的痛苦并延长了操作时间。我们自1993年起,对30例食管静脉曲张破裂出血的患者在硬化剂治疗前后给予奥曲肽治疗,并与15例单纯硬化剂治疗者进行比较。 1 资料与方法 1.1 病例选择 45例均为乙型肝炎肝硬化食管静脉破裂出血的患者。食管静脉出血由胃镜检查证实,随机分为两组。硬化 Cirrhosis esophageal varices bleeding is common in critical digestive medicine, case fatality rate as high as 22% to 84%. Sclerotherapy treatment to control bleeding and prevention of re-bleeding effect is certainly, but the operation is often limited by the bleeding when the field of vision is unclear, injection needle eye Yong bleeding and bleeding. Although compression of the balloon or cannula after injection of sclerosant increases the patient’s pain and prolongs the operating time. Since 1993, 30 patients with esophageal variceal bleeding have been treated with octreotide before and after sclerotherapy and compared with 15 patients with sclerotherapy alone. 1 Materials and Methods 1.1 Case Selection 45 cases of hepatitis B cirrhosis patients with esophageal variceal bleeding. Esophageal venous bleeding confirmed by gastroscopy were randomly divided into two groups. hardening